2019
DOI: 10.1002/14651858.cd013437
|View full text |Cite
|
Sign up to set email alerts
|

Non-corticosteroid adjuvant therapies for acute bacterial meningitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…73 Robust neuroinflammation is considered to be a major driver of the hearing loss associated with bacterial meningitis, and adjuvant corticosteroids (but not noncorticosteroid adjuvants) in combination with antibiotics have proved to reduce the risk of hearing loss and some other neurologic deficits in adults and children. [74][75][76] Predictive markers for neurologic outcomes, including cognitive impairment, in bacterial meningitis are clearly needed.…”
mentioning
confidence: 99%
“…73 Robust neuroinflammation is considered to be a major driver of the hearing loss associated with bacterial meningitis, and adjuvant corticosteroids (but not noncorticosteroid adjuvants) in combination with antibiotics have proved to reduce the risk of hearing loss and some other neurologic deficits in adults and children. [74][75][76] Predictive markers for neurologic outcomes, including cognitive impairment, in bacterial meningitis are clearly needed.…”
mentioning
confidence: 99%